Oblique Subcostal Tap Block Efficacy in Laparoscopic Cholecystectomy

NCT ID: NCT02707250

Last Updated: 2016-03-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Laparoscopic cholecystectomy although a minimally invasive procedure, may be accompanied by considerable pain after surgery. More recently transversus abdominis plane (TAP) block was extensively studied as a potential analgesic maneuver after laparoscopic cholecystectomy. The subcostal approach (OSTAP block) is a variation on the TAP block that produces reliable supraumbilical analgesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Laparoscopic cholecystectomy is a minimally invasive widespread surgical procedure, with postoperative lower pain scores and quick recovery of the patient. However some of patients may complain of considerable pain after surgery . There are several approaches to postoperative pain management after laparoscopic cholecystectomy such as patient-controlled analgesia with opioids (IV-PCA), neuraxial blocks, intraperitoneal injection of local anesthetics, wound infiltration, each being more or less effective, with specific side effects.

The transversus abdominis plane block (TAP-Block) is a regional analgesia technique that comes as an alternative to "classical" procedures of postoperative analgesia. Described by Rafi and McDonnell et al. this technique has undergone some changes over times, which increased its efficiency. Thus, Hebbard et al. described ultrasound subcostal oblique approach (OSTAP) of the block allowing analgesia in both the upper and lower abdomen, with a lower rate of complications due to the direct ultrasound visualization. Different studies confirmed the analgesic efficacy of this technique and the postoperative opioid sparing effect after laparoscopic cholecystectomy .

Traditionally, the transversus abdominis plane block is achieved with classical amino-amides local anesthetics, bupivacaine, levobupivacaine and ropivacaine being the most commonly used .

Based on the local anesthetic properties of pethidine, a synthetic opioid, our study aimed to evaluate prospectively the analgesic efficacy of pethidine in achieving transversus abdominis plane block by ultrasound oblique subcostal approach in patients scheduled for elective laparoscopic cholecystectomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Oblique subcostal tap block with normal sterile saline ,20 ml, bilateral, single shot,24h

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Tap Block performed with normal sterile saline 20 ml on the right side and 20 ml on the left side

Bupivacaine

Oblique subcostal tap block with bupivacaine 0,25% ,20 ml, bilateral, single shot,24h

Group Type ACTIVE_COMPARATOR

Bupivacaine

Intervention Type DRUG

Tap Block performed with Bupivacaine 0,25% 20 ml on the right side and 20 ml on the left side.

Pethidine

Oblique subcostal tap block with pethidine 1% ,10 ml,bilateral,single shot,24h

Group Type ACTIVE_COMPARATOR

Pethidine

Intervention Type DRUG

Tap Block performed with pethidine 1% 10 ml on the right side and 10 ml on the left side

Pethidine Local Infiltration (L.I.)

Local infiltration of pethidine 1% at trocar insertion sites, 5ml /site, 24h compared with Tap Block with pethidine 1%

Group Type ACTIVE_COMPARATOR

Pethidine Local Infiltration (L.I)

Intervention Type DRUG

Local infiltration of port sites (trocar insertion sites) with pethidine 1% 5ml each port (trocar site) ,4 ports total 20 ml pethidine 1%

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo

Tap Block performed with normal sterile saline 20 ml on the right side and 20 ml on the left side

Intervention Type DRUG

Bupivacaine

Tap Block performed with Bupivacaine 0,25% 20 ml on the right side and 20 ml on the left side.

Intervention Type DRUG

Pethidine

Tap Block performed with pethidine 1% 10 ml on the right side and 10 ml on the left side

Intervention Type DRUG

Pethidine Local Infiltration (L.I)

Local infiltration of port sites (trocar insertion sites) with pethidine 1% 5ml each port (trocar site) ,4 ports total 20 ml pethidine 1%

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tap Block Placebo Tap Block Bupivacaine Tap Block Pethidine Pethidine Local Infiltration

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anaesthesiologists (ASA) I-II
* Age over 18years old
* patients scheduled elective laparoscopic cholecystectomy

Exclusion Criteria

* Open cholecystectomy - excluded due to increased levels of pain in open procedures
* Renal dysfunction (Serum Cr \> 1.2) - excluded due to potential altered metabolism of anesthetic and pain medications
* Coagulopathy or anticoagulation - increased risk of bleeding from nerve block injection
* Allergy or contraindication to any of the study medications or anesthetic agents
* Chronic opioid analgesic use at home - excluded due to potential difficulty in assessing pain caused by the procedure alone
* Patient inability to properly describe postoperative pain to investigators (language barrier, dementia, delirium, psychiatric disorder)
* Pregnancy
* Prisoners
* Patient or surgeon refusal
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iuliu Hatieganu University of Medicine and Pharmacy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Breazu Caius Mihai

Dr.Breazu Caius Mihai MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniela Ionescu, MD

Role: STUDY_DIRECTOR

University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca,Romania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Regional Institute of Gastroenterology and Hepatology "Prof.dr.Octavian Fodor"

Cluj-Napoca, Cluj, Romania

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Romania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Caius M Breazu, MD

Role: CONTACT

+40743010012

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Caius M Breazu, MD

Role: primary

0040743010012

References

Explore related publications, articles, or registry entries linked to this study.

Breazu C, Margarit S, Bartos A, Ionescu D. Postoperative Analgesia after Laparoscopic Cholecystectomy - Prospective, Randomized, Double Blind, Control Trial. Chirurgia (Bucur). 2022 Oct;117(5):563-571. doi: 10.21614/chirurgia.2769.

Reference Type DERIVED
PMID: 36318686 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IuliuHatieganuU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Magnesium Sulphate in Oblique Subcostal TAP Block
NCT06148168 NOT_YET_RECRUITING PHASE2/PHASE3